ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
ViraCyte Announces Positive Phase 2 Trial Results
August 24, 2017ViraCyte announced publication of positive data from a Phase 2 clinical trial evaluating its T-cell immunotherapy product, Viralym-M. The results were reported by ViraCyte lead investigators at Baylor College of Medicine in the Journal of Clinical Oncolog -
Endocyte and Seattle Children’s Research Institute to Collaborate on Endocyte’s Small Molecule Drug
March 13, 2017Endocyte, a developer of targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy, announced their plan to collaborate with Seattle Children’s Research Institute and -
Amgen, Immatics ink deal potentially worth over $1 billion to develop cancer immunotherapies
January 10, 2017Amgen and Immatics Biotechnologies on Monday announced an agreement potentially worth more than $1 billion to jointly develop next-generation T-cell engaging bispecific immunotherapies targeting multiple cancers
Pharma Sources Insight January 2025
